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CAPS1 and CAPS2 regulate dense-core vesicle re-
lease of transmitters and hormones in neuroendo-
crine cells, but their precise roles in the secretory
process remain enigmatic. Here we show that
CAPS2/ and CAPS1+/;CAPS2/ mice, despite
having increased insulin sensitivity, are glucose intol-
erant and that this effect is attributable to a marked
reduction of glucose-induced insulin secretion. This
correlates with diminished Ca2+-dependent exocyto-
sis, a reduction in the size of the morphologically
docked pool, a decrease in the readily releasable
pool of secretory vesicles, slowed granule priming,
and suppression of second-phase (but not first-
phase) insulin secretion. In b cells of CAPS1+/;
CAPS2/ mice, the lowered insulin content and
granule numbers were associated with an increase
in lysosome numbers and lysosomal enzyme activity.
We conclude that although CAPS proteins are not re-
quired for Ca2+-dependent exocytosis to proceed,
they exert a modulatory effect on insulin granule
priming, exocytosis, and stability.
INTRODUCTION
Endocrine amine and peptide-releasing cells use large dense-
core vesicles (LDCVs) for storage and release of hormones
(Kasai, 1999). Pancreatic b cells play an essential role in glucose
homeostasis by secreting insulin. Insulin release is initiated by
glucose metabolism that increases the ATP/ADP ratio, leading
to inhibition of KATP channels with resultant membrane depolar-
ization and initiation of electrical activity (Ashcroft and Rorsman,
1989). During electrical activity, influx of Ca2+ via voltage-gated
Ca2+ channels and the resultant increase in [Ca2+]i triggers insu-
lin release but also the mobilization of ‘‘new’’ LDCVs for later exo-
cytosis (Jing et al., 2005; Ohara-Imaizumi et al., 2004; Barg,
2003).
Every b cell contains over 10,000 LDCVs, but only a small frac-
tion (1%) of these belong to the readily releasable pool (RRP),
i.e., the granules that are immediately available for release. Most
granules instead belong to a nonreleasable ‘‘reserve pool.’’ Part
of the reserve pool (10%) is morphologically docked below theplasma membrane (Olofsson et al., 2002). To maintain the exo-
cytotic capacity, exocytosis of RRP granules must be balanced
by the mobilization of new granules from the reserve pool (Barg,
2003). The latter process is controlled by the intracellular ATP/
ADP ratio and is accelerated by moderate (subexocytotic) eleva-
tions of [Ca2+]i (Gromada et al., 1999; Olsen et al., 2003). How-
ever, the molecular mechanisms regulating granule mobilization
are not well understood.
Among the proteins that have been suggested to specifically
regulate LDCV exocytosis and hormone release are Ca2+-
dependent activator protein for secretion 1 (CAPS1) and CAPS2
(Speidel et al., 2003; Walent et al., 1992). CAPS1 was first iden-
tified as an essential regulator of Ca2+-dependent catecholamine
release in PC12 cells. Subsequent studies indicated that CAPS1
is required for a secretory step that follows ATP-dependent prim-
ing (Ann et al., 1997; Grishanin et al., 2004; Walent et al., 1992).
Antibody inhibition studies in pancreatic b cells (Olsen et al.,
2003), chromaffin cells (Elhamdani et al., 1999), and melano-
trophs (Rupnik et al., 2000) implicate CAPS1 in LDCV exocytosis,
possibly as a modulator of fusion pore formation (Elhamdani
et al., 1999). CAPS1/ mice die perinatally, but functional stud-
ies in chromaffin cells from embryonic CAPS1/ mice have re-
vealed defects in catecholamine loading or storage. Chromaffin
cells from adult CAPS1+/ mice (in which CAPS1 expression is
reduced by 35%) display reduced exocytosis and a lower num-
ber of morphologically docked granules (Speidel et al., 2005).
CAPS2, a highly homologous paralog of CAPS1, has been
shown to regulate neurotrophin release, and ablation of this pro-
tein results in abnormal cerebellar development and impaired
short-term plasticity (Sadakata et al., 2004, 2007a). Thus, the
role of CAPS proteins, contrary to earlier claims (Renden et al.,
2001; Tandon et al., 1998), may not be limited to control of
LDCV exocytosis.
Despite studies in different organisms, including C. elegans
(Speese et al., 2007) and Drosophila (Renden et al., 2001), and
the use of various cell types as model systems, the molecular
steps of CAPS action remain elusive. Moreover, CAPS1 and
CAPS2 are coexpressed in several tissues, but functional differ-
ences between the two isoforms remain to be documented
(Sadakata et al., 2007b; Speidel et al., 2003). Here we explore
the roles of CAPS1 and CAPS2 in b cell insulin secretion using
adult CAPS2/ and CAPS1+/;CAPS2/ mice. We have
thereby been able to compare CAPS1 and CAPS2 function.
Our data indicate that the two CAPS isoforms have distinct roles
in b cell function.
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Expression Pattern of CAPS1 and CAPS2
in the Endocrine Pancreas
The localization of CAPS1 and CAPS2 proteins in islets of Lang-
erhans was studied by immunocytochemistry using isoform-
specific antibodies. CAPS1 and CAPS2 immunoreactivity
showed a similar distribution pattern (Figure 1). Both CAPS iso-
forms were expressed in insulin-producing b cells and glucagon-
producing a cells. Only weak, unspecific signals were obtained
by labeling islets from CAPS2/ mice with CAPS2-specific
antibodies (Figure 1, bottom), thus confirming the specificity of
the antibody. The specificity of the CAPS1 antibody was con-
firmed previously (Speidel et al., 2005).
Insulin Content and Release from Wild-Type
and CAPS-Deficient Pancreatic Islets
CAPS1 regulates vesicular storage of catecholamines in embry-
onic chromaffin cells, and its ablation leads to exocytosis of
empty LDCVs (Speidel et al., 2005). Does ablation of this protein
also interfere with hormone storage and release in peptide-
secreting cells like the pancreatic b cell? We addressed this
question by measuring insulin secretion in freshly isolated pan-
creatic islets obtained from wild-type (WT), CAPS2/, and
CAPS1+/;CAPS2/ mice (Figure 2A). In WT islets, elevating
glucose from 1 mM to 20 mM stimulated insulin release
>6-fold. Basal and glucose-stimulated insulin secretion from
CAPS2/ islets was reduced by 35 and 45%, respectively.
In CAPS1+/;CAPS2/ islets, glucose-stimulated insulin se-
cretion (GSIS) was reduced to an extent (50%–60%) similar to
basal secretion as compared to WT levels and was lower than
in CAPS2/ islets (p < 0.005; Figure 2A). Insulin secretion
evoked by stimulation with 50 mM K+ was reduced by 35% in
CAPS2/ and 50% in CAPS+/;CAPS2/ islets. We finally
tested the effects of the incretin hormone GLP-1, which acts
by stimulating cAMP production. This peptide potentiated
GSIS1.4-, 1.6-, and 1.8-fold in WT, CAPS2/, and CAPS1+/;
CAPS2/ islets, respectively (stimulation by GLP-1 statistically
significant versus 20 mM glucose alone for all mouse strains; p <
0.002). Collectively, these data indicate that the effects of CAPS1
and CAPS2 are additive and are exerted downstream of Ca2+
entry.
We estimated the dynamics of GSIS in WT and CAPS2/ is-
lets by measuring insulin secretion from islets during 5, 10, 30,
and 60 min of incubation and calculated the net insulin release.
This provides an indication of the time course of insulin secretion.
Data obtained by this protocol resemble those obtained by
pancreas perfusion (Jing et al., 2005; Schulla et al., 2003), albeit
with a lower temporal resolution. In WT islets, insulin secretion in
the presence of 20 mM glucose peaked after 5 min (first phase)
and then proceeded at a much lower rate (20%–25% of the
peak; second phase). In CAPS2/ islets, the amplitude of
first-phase release was not significantly reduced, but second-
phase secretion was almost abolished (reduced by 70%–80%;
p < 0.05; Figure 2B).
The observed reduction in insulin secretion cannot be ex-
plained by lowered insulin content: insulin content was not
altered in CAPS2/ islets and was only reduced by 25% in
CAPS1+/;CAPS2/ islets (Figure 2C). Thus, inhibition of insulin
58 Cell Metabolism 7, 57–67, January 2008 ª2008 Elsevier Inc.secretion is much stronger (50%–60%) than can be accounted
for by the lowered insulin content. Islet proinsulin content was
not affected by CAPS ablation (Figure 2D), and proinsulin release
from CAPS-deficient islets was not stimulated beyond WT levels
by glucose (data not shown).
The reduction of insulin secretion from CAPS2/ islets can-
not be accounted for by increased somatostatin secretion, and
glucose-evoked release of this inhibitory hormone was signifi-
cantly reduced in islets lacking CAPS2 (see Figure S1A avail-
able online). Interestingly, glucagon secretion was increased
in both CAPS2/ and CAPS1+/;CAPS2/ islets, possibly
reflecting relief from paracrine inhibition by insulin and/or
somatostatin. Importantly, glucose remained capable of inhibit-
ing glucagon release in the CAPS knockout (KO) strains
(Figure S1B).
Figure 1. Immunocytochemical Localization of CAPS Proteins in
Intact Islets
Immunocytochemical detection of CAPS1 or CAPS2 (left), insulin or glucagon
(middle), and overlay (right) in islets from wild-type and CAPS2/ mice
(bottom row). Scale bar: 50 mm.
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CAPS Proteins Regulate Insulin SecretionFigure 2. Effects of CAPS2 and CAPS1 Ablation on Insulin Secretion,
Islet Insulin Content, and Islet Proinsulin Content
(A) Average insulin release from islet batches of 7 wild-type (WT), 8 CAPS2/,
and 8 CAPS1+/;CAPS2/ islets after 60 min incubation at 37C in the pres-
ence of 1 mM glucose (1 G), 1 mM glucose and 100 nM GLP-1 (1 G + GLP-1),
1 mM glucose and 50 mM K+ (1 G + K), 5 mM glucose (5 G), 20 mM glucose
(20 G), or 20 mM glucose and 100 nM GLP-1 (20 G + GLP-1). Data are mean
values ± SEM of 12 experiments. CAPS1+/;CAPS2/ values were signifi-
cantly different from WT values under all conditions except for 5 mM glucose,
with p < 0.003. Levels of significance are shown for CAPS2/ versus WT
values as well as CAPS1+/;CAPS2/ versus CAPS2/ values. *p < 0.05;
**p < 0.01; ***p < 0.001; ****p < 0.0001.
(B) Dynamics of glucose-stimulated insulin secretion measured 0, 5, 10, 30,
and 60 min after onset of glucose stimulation (20 mM glucose) from WT and
CAPS2/ islets. The horizontal line indicates release rates at 1 mM glucose.
Data are mean values ± SEM from 7–8 experiments per group. *p < 0.05;
****p < 0.0001.Single-Cell Exocytosis in Wild-Type
and CAPS-Deficient b Cells
Ca2+-dependent exocytosis in b cells was monitored as in-
creases in whole-cell membrane capacitance. Exocytosis was
elicited by trains of ten 500 ms voltage-clamp depolarizations
from 70 mV to 0 mV applied at 1 Hz. In both WT and KO
mice, we frequently observed a spontaneous increase in capac-
itance at hyperpolarized membrane potentials proceeding at
rates of 9 ± 1 fF/s, 4 ± 1fF/s (p < 0.001 versus WT), and
3 ± 1 fF/s (p < 0.001 versus WT; n = 27–30) in WT, CAPS2/,
and CAPS1+/;CAPS2/ b cells, respectively. Thus, basal exo-
cytosis is reduced by >50% in CAPS-deficient islets, an effect
similar to the inhibition of basal (1 mM glucose) insulin secretion
(see Figure 2A). Spontaneous exocytosis would result in empty-
ing of the RRP. Analysis of depolarization-evoked exocytosis
was therefore confined to experiments not displaying spontane-
ous basal exocytosis. In a series of 30 experiments on WT cells,
only 8 experiments had a stable prestimulatory capacitance.
These were also the cells with the greatest exocytotic responses.
Although the spontaneous capacitance increase was less prom-
inent in KO b cells, we nevertheless selected the 8 cells in each
group with the greatest responses for comparison with the WT
data. Figure 3A shows representative examples of remaining
recordings from WT and KO mice. The capacitance increases
in WT, CAPS2/, and CAPS1+/;CAPS2/ b cells evoked by
the trains averaged 293 ± 44 fF, 134 ± 14 fF (p < 0.003 versus
WT), and 129 ± 18 fF (p < 0.002 versus WT), respectively.
We calculated the capacitance increase per pulse. Figure 3B
summarizes the data for WT and KO cells. In WT b cells, the exo-
cytotic responses fall from 40 fF/pulse during the two first
pulses to <20 fF/pulse during pulses 6–10. We used the sum of
the responses to the two first pulses to estimate the size of the
RRP (Kanno et al., 2004). The RRP in WT, CAPS2/, and
CAPS1+/;CAPS2/ b cells was thus estimated to be 84 ±
16 fF, 40 ± 4 fF (p < 0.004 versus WT), and 44 ± 7 fF (p < 0.007
versus WT), respectively. Exocytosis in CAPS2/ and
CAPS1+/;CAPS2/ b cells was similarly reduced relative to
that seen in WT cells throughout the train. These effects cannot
be explained by inhibition of Ca2+ influx, as peak Ca2+ current
amplitudes were not affected (averaged 57 ± 12 pA, 68 ±
15 pA, and 53 ± 15 pA during depolarizations to 0 mV in WT,
CAPS2/, and CAPS1+/;CAPS2/ b cells, respectively).
CAPS1/;CAPS2/ mice die shortly after birth, but we were
able to perform a few experiments on embryonic (E19) b cells
from such mice. In a series of six experiments, exocytosis from
CAPS1/;CAPS2/ b cells evoked by a train of ten depolariza-
tions averaged 77 ± 15 fF (Figure S2). Although we were unable
to make the corresponding measurements in embryonic WT
cells, it nevertheless seems justifiable to conclude that CAPS
proteins are not necessary for depolarization-evoked b cell
exocytosis.
(C) Islet insulin content from 4 WT, 5 CAPS2/, and 5 CAPS1+/;CAPS2/
mice (labeled as in [A]). Data are mean values ± SEM from 9–13 experiments.
*p < 0.05.
(D) Islet proinsulin content (ng/mg protein) from 4 WT, 5 CAPS2/, and
5 CAPS1+/;CAPS2/ mice (labeled as in [A]). Data are mean values ± SEM
from 9–13 experiments.
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CAPS Proteins Regulate Insulin SecretionFigure 3. Effects of CAPS1 and CAPS2 Ablation on Single-Cell Exocytosis in Pancreatic b Cells
(A) Exocytosis evoked by trains of ten depolarizations (mV) and monitored as increases in cell capacitance (DC) in single WT,CAPS2/, andCAPS1+/;CAPS2/
b cells.
(B) Average increase in capacitance per pulse (DCn  DCn  1) displayed against pulse number (n) during the trains. Data are mean values ± SEM from 8–9 cells.
(C) Exocytotic responses in single b cells during repetitive stimulation (12 500 ms depolarizations to 0 mV applied at 0.3 Hz). Amplitude of response to first de-
polarization (C0) is taken as 100%. Data are mean values ± SEM of 11 cells in both indicated groups. *p < 0.05; **p < 0.01.
(D) DC evoked by intracellular dialysis of a Ca2+-containing patch electrode solution (free [Ca2+]i  1.5 mM).The ability of the b cell to sustain exocytosis was also studied
in intact cells using the perforated-patch whole-cell technique. In
this series of experiments, 12 500 ms depolarizations to 0 mV
were applied every3 s (Figure 3C). In WT cells, exocytosis dur-
ing the train decreased by only 24% ± 18% (n = 11). CAPS2/
b cells were less capable of maintaining the exocytotic capacity
during repetitive stimulation, and the responses declined by
71% ± 8% during the train (n = 11; p < 0.01 versus WT).
Finally, we measured the rate of capacitance increase in
b cells in which exocytosis was evoked by dialyzing the cell in-
terior with 1.5 mM Ca2+ via the recording electrode (Figure 3D).
This protocol bypasses the effects of Ca2+ entry via the Ca2+
channels and may affect processes regulated by the global
rather than the near-membrane [Ca2+]i (Barg, 2003; Rorsman
et al., 2000). Whereas loss of CAPS2 did not affect exocytosis
elicited by this paradigm, a strong (50%) reduction was seen
in the CAPS1+/;CAPS2/ b cells (Figure 3D). The average
rates of capacitance increase were 13.0 ± 1.5 fF/s, 13.5 ±
1.8 fF/s, and 6.5 ± 0.8 fF/s in WT, CAPS2/, and CAPS1+/;
60 Cell Metabolism 7, 57–67, January 2008 ª2008 Elsevier Inc.CAPS2/ b cells, respectively (p < 0.0005 versus WT and
CAPS2/; n = 20–23).
Analysis of Vesicular Fusion Events in Intact Islets
from CAPS2/ and Wild-Type Mice
We next used the fluorescent fluid-phase tracer sulforhodamine
B (SRB) to monitor single-vesicle exocytosis. When cells are
bathed in SRB, the dye diffuses through the fusion pore of gran-
ules undergoing exocytosis (an exocytotic event was defined as
the rapid appearance of a fluorescent vesicular structure) and
labels their lumen. The dye-filled volume remains visible until
the granular membrane collapses into the plasma membrane
(Takahashi et al., 2002). Within 5 min after increasing the glucose
concentration from 5 mM (no signals) to 20 mM glucose, tran-
sient bright spots appeared throughout the image plane, but
invariably in close proximity to the edge of the cells in both WT
and CAPS2/ islets (Figure 4A; see also Movies S1 and S2).
These transients had an approximate diameter of 0.5 mm, similar
to that reported previously by others (Takahashi et al., 2002) and
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mined by electron microscopy (Olofsson et al., 2002), arguing
that the events we observed reflect exocytosis of insulin-containing
LDCVs. We counted the number of fluorescence transients in an
imaged area (1000 mm2) during 5 min recording (14 islets from 7
mice each; Figure 4B). The number of exocytotic fusion events
was reduced by 50% in CAPS2/ b cells compared to WT cells.
Figure 4. Quantification of Individual Vesicular Fusion Events
in Pancreatic Islets from WT and CAPS2/ Mice after Glucose
Challenge
(A) Two-photon confocal images of isolated islets bathed in sulforhodamine B.
Movies (Movies S1 and S2, available online) were recorded at 1 Hz for 5 min.
Outlined areas highlight the analyzed fields, and circles with successive num-
bers indicate positions of individual fusion events observed in response to a
20 mM glucose challenge. Scale bar: 10 mm.
(B) Average number of fusion events per field from 14 WT and 14 CAPS2/
islets (from 7 mice each). Data are mean values ± SEM. ***p < 0.001.Morphometric Analysis of Insulin Granule
Distribution in Isolated Islets
We next analyzed the ultrastructure of mutant b cells to search
for possible defects in secretory granule biogenesis or granule
docking at the plasma membrane. Ultrathin sections from intact
islets of WT, CAPS2/, and CAPS1+/;CAPS2/ mice were
analyzed by electron microscopy (Figure 5A). To investigate
whether the number and distribution of LDCVs were affected
by ablation of CAPS1 and CAPS2, we determined the relative
granule density in 0.2 mm concentric shells below the plasma
membrane (Figure 5B). Relative granule density in b cells from
CAPS2/ mice was significantly reduced (15%) only in the
first 0.2 mm below the plasma membrane (i.e., the vesicles
that are morphologically docked). In b cells from CAPS1+/;
CAPS2/ mice, the granule density was reduced in all shells
up to 1 mm, and the number of morphologically docked granules
was 44% lower than in WT b cells. The total granule density was
only marginally reduced in CAPS2/ b cells but was 25% lower
in CAPS1+/;CAPS2/ b cells—i.e., similar to the reduction of
islet insulin content (Figure 5C). The lower number of morpholog-
ically docked granules seen in b cells from both KO strains was
not associated with any corresponding accumulation of granules
in other areas of the cells.
Effects of CAPS Ablation on Lysosome Numbers
and Lysosomal Enzyme Activity
Islet insulin content and granule number were reduced by 25% in
CAPS1+/;CAPS2/ mice compared to CAPS2/ and WT
mice. The finding that the proinsulin levels were unaffected in
CAPS1+/;CAPS2/ islets indicates that the decrease in gran-
ule number does not result from reduced granule biogenesis.
We examined whether this effect instead results from acceler-
ated insulin granule degradation. Insulin granule degradation is
mediated by crinophagy, which involves fusion of secretory
granules with lysosomes and ultimate destruction of the
secretory material (Borg and Schnell, 1986; Halban, 1991; Orci
et al., 1984). To estimate the extent of crinophagy, we compared
the density of secondary lysosomes in WT, CAPS2/, and
CAPS1+/;CAPS2/ b cells (Figures 6A and 6B). Lysosomes
of different sizes and shapes were found in all three mouse
strains (Figure 6A), but the cellular density of lysosomes in
CAPS1+/;CAPS2/ b cells was 60% higher than in WT and
CAPS2/ b cells.
The increased number of lysosomes in CAPS1+/;CAPS2/
b cells correlated with an increased activity of the lysosomal
carboxyl proteinase cathepsin D, which was 2.4-fold higher in
CAPS1+/;CAPS2/ islets than in WT islets (Figure 6C). The
activities of other common lysosomal enzymes, such as acid
phosphatase, a-glucosidase, and N-acetyl-b-glucosidase, were
affected either marginally or not at all in CAPS mutant mice
(Figure 6C). We conclude that the functionality of the lysosomal
system in islet cells depends on CAPS proteins.
In Vivo Glucose Tolerance, Pancreatic Insulin
Release, and Insulin Sensitivity in Wild-Type
and CAPS-Deficient Mice
Pancreatic islets in situ receive extensive neuronal input from
parasympathetic nerve endings (Ahren, 2000). CAPS1 and
CAPS2 proteins are also expressed in neuronal tissues and
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Ablation on Insulin Granule Number and
Distribution in Pancreatic Islets
(A) Upper row: electron micrographs of islet sec-
tions (scale bar: 2 mm). Lower row: magnified areas
of individual b cells (scale bar: 0.5 mm). Black
dashed lines indicate a distance of 0.2 mm from
the plasma membrane.
(B) Relative density of insulin granules located in
0.2 mm concentric shells in the first 2 mm below
the plasma membrane. Data are mean values ±
SEM of granule numbers/cell section within a given
distance from the plasma membrane (n = 29).
*p < 0.05.
(C) Total granule density/cell section. Data are
mean values ± SEM of the total number of gran-
ules/mm2 cytosol area (n = 29 from 3 mice each;
labeled as in [B]). ***p < 0.001.
sensitivity is improved in both KO strains,
indicating that the impaired glucose toler-
ance seen in the CAPS-deficient mice
cannot be attributed to insulin resistance.
DISCUSSION
CAPS is essential for exocytosis of
LDCVs in a number of (neuro)endocrine
cells and model organisms (Olsen et al.,
2003; Renden et al., 2001; Rupnik et al.,
2000; Speidel et al., 2005). Whether
CAPS1 and CAPS2 are mutually ex-
changeable or subserve distinct func-
tions is not clear. Here we have com-may thus affect insulin secretion in an indirect way by modulating
the activity of nerves ending within the pancreatic islets. We
therefore evaluated the effect of CAPS ablation on insulin release
and glucose homeostasis in vivo. CAPS2/ and CAPS1+/;
CAPS2/ mice had the same body weight and basal plasma
glucose concentrations as their WT counterparts. Nonfasted
plasma insulin levels tended to be slightly reduced in the KO
mice (Figure S3). In WT mice, glucose increased plasma insulin
concentrations >2.5-fold both 3 and 10 min after the glucose
load. In CAPS2/ and CAPS1+/;CAPS2/ mice, basal insulin
levels as well as insulin release measured 3 min after glucose
challenge were similar to WT values. However, insulin release
measured at 10 min after the challenge was reduced by 40%
and55% inCAPS2/ andCAPS1+/;CAPS2/mice, respec-
tively. A reduced insulin secretory capacity may explain the
impaired glucose tolerance observed 45 min after the glucose
load: although plasma insulin levels in the KO mice are no longer
significantly different from WT data at this time point, it should be
noted that the plasma glucose concentration is 30% higher in the
KO mice (Figure 7B), which may obscure the true extent of the
secretory deficiency in the KO mice. This notion is supported
by the strong reduction of second-phase GSIS observed under
glucose-clamp conditions in vitro (Figure 2B).
We also compared the insulin sensitivity of WT, CAPS2/,
and CAPS1+/;CAPS2/ mice. Figure 7C shows that insulin
62 Cell Metabolism 7, 57–67, January 2008 ª2008 Elsevier Inc.pared b cell function in adult WT, CAPS2/, and CAPS1+/;
CAPS2/mice. This comparison allows us to dissect the contri-
bution of the individual CAPS isoforms to b cell exocytosis. Our
data underpin the hypothesis that CAPS proteins are important
modulators of LDCV-mediated insulin secretion with different
roles in b cell exocytosis and granule stability.
CAPS Ablation Inhibits Insulin Secretion
We show that insulin secretion evoked by 20 mM glucose or
50 mM K+ is reduced by 40% in CAPS2/ islets (Figure 2A).
A similar reduction was observed in the capacitance measure-
ments (Figures 3A and 3B) and sulforhodamine imaging experi-
ments (Figure 4). This effect was not associated with any sig-
nificant reduction of the whole-cell Ca2+ current amplitude, and
the number of morphologically docked granules was only mar-
ginally reduced (by <20%; Figure 5B). Insulin secretion evoked
by high extracellular K+ in the absence of an insulin-releasing
glucose concentration reflects exocytosis of granules that have
progressed into the RRP (Olofsson et al., 2002). The finding
that deletion of CAPS2 affects insulin secretion evoked by high
K+ and glucose similarly suggests that CAPS2 in b cells, by anal-
ogy to what was previously postulated for CAPS1 in PC12 cells
(Grishanin et al., 2004), modulates exocytosis at steps immedi-
ately preceding granule fusion: if it acted prior to granule priming,
secretion evoked by high K+ would be expected to be relatively
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(A) Electron micrographs of islet sections. Arrows highlight individual lysosomes. Insets show examples of lysosomes at higher magnification. (Scale bar: 1 mm;
inset scale bar: 0.2 mm.)
(B) Cellular density of lysosomes in b cells. Data are mean values ± SEM of the total number of lysosomes/mm2 cytosol area (n = 29 from 3 mice each).
*****p < 0.00004.
(C) Activity of different lysosomal enzymes in freshly isolated islets. Enzyme activities are expressed as tyrosine equivalents or 4-methylumbelliferone equivalents
liberated per min per g protein. Data are mean values ± SEM for groups of 50 islets from 13–14 experiments (8 mice each). *p < 0.05; ***p < 0.01; *****p < 0.00001.less affected than that evoked by glucose and GLP-1. In line with
previous observations in clonal cells (Fujita et al., 2007; Sadakata
et al., 2007a) we found that basal exocytosis and insulin release
were significantly affected by CAPS deficiency, suggesting
that CAPS proteins are also important for spontaneous/basal
exocytosis.
Distinct Roles ofCAPS1 andCAPS2 in bCell Exocytosis?
Membrane depolarizations give rise to local increases of high
(R10 mM) Ca2+ concentrations in the vicinity of the plasma mem-
brane that do not equilibrate throughout the cell (Bokvist et al.,
1995). Exocytosis evoked by this stimulation paradigm is clearly
regulated by CAPS2, as the size of the RRP was affected simi-
larly in CAPS2/ and CAPS1+/;CAPS2/ b cells. By contrast,
the exocytotic capacity of the b cells did not correlate well with
the size of the morphologically docked pool (MDP), which was
reduced by 17% and 44% in CAPS2/ and CAPS1+/;
CAPS2/ b cells, respectively, whereas the functionally defined
RRP decreased by >50% in both strains. However, it should be
kept in mind that the RRP only represents a subset (20%) of the
docked pool and that a reduction of the MDP need not automat-
ically result in a decrease in RRP (Olofsson et al., 2002). The
dichotomy between the MDP and the RRP is elegantly illustratedin recent studies of granuphilin KO b cells, wherein exocytosis
was actually increased despite a marked reduction of the MDP
(Gomi et al., 2005).
The similar effects of CAPS1 and CAPS2 ablation on RRP size
contrast with the responses to a uniform increase in [Ca2+]i to
1.5 mM via application through the recording electrode, a proto-
col believed to involve the continuous replenishment of the RRP
(Rorsman et al., 2000). This suggests that recruitment of gran-
ules for release might not be a uniform process and that, espe-
cially under more protracted stimulations (such as intracellular
dialysis with 1.5 mM [Ca2+]i), physical translocation of granules
toward the plasma membrane might become rate limiting,
whereas near-membrane granules might be sufficient to sustain
refilling of the RRP during trains of depolarizations. Indeed,
recent total internal reflection fluorescence (TIRF) imaging
measurements have confirmed that RRP refilling does involve
physical translocation of granules (Ohara-Imaizumi et al.,
2007). This raises the interesting possibility that CAPS1 and
CAPS2 might fulfill distinct functions in b cell exocytosis, that
CAPS1 might somehow be required for the approach of the
granules toward the plasma membrane, and that a hierarchy of
exocytosis regulation by different CAPS isoforms might exist:
CAPS1 regulates the movements of secretory granules towardCell Metabolism 7, 57–67, January 2008 ª2008 Elsevier Inc. 63
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events, including the maintenance of the RRP (Olsen et al.,
2003). This scenario is supported by the inability of CAPS2/
Figure 7. In Vivo Measurements of Hormone Secretion and Glucose
Tolerance
(A and B) Time course of insulin secretion (A) and plasma glucose concentra-
tion (B) in response to an intraperitoneal glucose injection at time 0 (11.1 mmol/
kg body weight). Data represent mean values ± SEM of 10 mice. Levels of sig-
nificance are shown for both CAPS2/ and CAPS1+/;CAPS2/ mice com-
pared to WT mice. *p < 0.05; **p < 0.01; ***p < 0.001.
(C) Time course of insulin-induced lowering of plasma glucose concentration.
Insulin (0.5 IU insulin/kg body weight) was injected intraperitoneally at time 0.
Data represent mean values ± SEM of 8–10 mice (legend as in [A]). Levels of
significance are shown for both CAPS2/ and CAPS1+/;CAPS2/ mice
compared to WT mice. *p < 0.05; **p < 0.01.
64 Cell Metabolism 7, 57–67, January 2008 ª2008 Elsevier Inc.cells to maintain the exocytotic capacity even during moderate
(0.33 Hz) stimulation with voltage-clamp pulses (Figure 3C),
whereas the strong reduction of near-membrane granules (in-
cluding the MDP) in CAPS1+/;CAPS2/ b cells is indicative
of defective forward (i.e., toward the plasma membrane) translo-
cation of granules. The differential regulation of exocytosis by
CAPS2 and CAPS1 might result from either distinct Ca2+ affini-
ties or compartmentalization within the cell, but our data do
not allow us to distinguish between these possibilities.
Number and Stability of Insulin Granules
after CAPS Ablation
CAPS1 ablation reduced the total granule density by 25%, which
was paralleled by a decrease in islet insulin content. There are at
least three alternative explanations for these findings: (1) CAPS1
regulates the biogenesis of insulin granules; (2) CAPS1 plays
a role in insulin processing and/or granule maturation; or (3)
CAPS1 regulates the intravesicular storage of insulin, and
CAPS1 deficiency leads to ‘‘leakage’’ of insulin out of the gran-
ules. The latter possibility is suggested by analogy to the situa-
tion in embryonic chromaffin cells where CAPS1 ablation results
in defects in the storage of catecholamines and exocytosis of
empty vesicles. However, the ultrastructural analysis failed to
document an increased number of empty granules in CAPS1+/;
CAPS2/ b cells (data not shown). It should be noted that pro-
insulin, unlike catecholamines that are imported into vesicles via
vesicular monoamine transporters, is packaged into LDCVs
already in the Golgi apparatus (Dodson and Steiner, 1998). Leak-
age of insulin out of the vesicles is also unlikely given the size and
hydrophilic nature of the peptide. Our finding that proinsulin con-
tent is not affected in KO islets argues instead that CAPS ablation
affects mature granules in which proinsulin has been converted
to insulin. Accordingly, both the density of lysosomes and the
activity of the lysosomal peptidase cathepsin D were strongly
increased in CAPS1+/;CAPS2/ islets. The consequences of
only CAPS2 ablation on these parameters were much milder, al-
though the effect on insulin secretion seen in the CAPS1+/;
CAPS2/ islets was only marginally stronger. Thus, CAPS1 ap-
pears to be particularly important for the maintenance of granule
stability. We acknowledge that we cannot completely exclude
the possibility that the observed effect on granule stability in
CAPS1+/;CAPS2/ b cells is a consequence of gene-dos-
age-related reduction in total CAPS levels. However, this seems
unlikely given that many other processes (depolarization-evoked
exocytosis and GSIS in vitro as well as in vivo) are reduced sim-
ilarly in CAPS1+/;CAPS2/ and CAPS2/ b cells. Future stud-
ies using CAPS1+/;CAPS2+/+ mice will clarify whether granule
number and stability depend on CAPS1 alone.
Like other endocrine cells, the b cell maintains a balance be-
tween insulin biosynthesis, secretion, and intracellular degrada-
tion. How CAPS proteins regulate granule numbers and stability
remains elusive. It can be speculated that CAPS1 provides gran-
ules with a ‘‘quality stamp’’ or ensures proper translocation of
granules, and that granules are shunted to the crinophagic path-
way in the absence of this protein. It is also possible that CAPS
ablation inhibits exocytosis of lysosomes as reported previously
(Liu et al., 2005), and that cellular accumulation of these organ-
elles stimulates crinophagy. It is interesting that the C. elegans
homolog of the granule-associated protein IA-2 has been shown
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CAPS Proteins Regulate Insulin Secretionin genetic studies to interact with CAPS (Cai et al., 2004). In sup-
port of this link, knockdown of IA-2 in MIN6 cells strongly re-
duces granule numbers and insulin secretion, and overexpres-
sion of IA-2 increases insulin stability (Harashima et al., 2005).
Similarly, b cells deficient for Rab3A (a GTP-binding protein
that directs granule trafficking) show a marked reduction in
insulin release that is associated with a compensatory 12-fold
increase of crinophagic structures (Marsh et al., 2007).
Comparisons with Other Cell Types
Overall, the present data extend published observations in chro-
maffin cells from adult CAPS1+/ mice and peptide-secreting
cells. A recent study implicates CAPS1 in the recruitment of
LDCVs into the RRP in PC12 cells (Fujita et al., 2007). Similarly,
ablation of the distantly related Munc13-1 proteins (Koch et al.,
2000) in pancreatic b cells selectively decreases second-phase
insulin release and sustained LDCV exocytosis (Kang et al.,
2006). Indeed, ablation of CAPS1 and CAPS2 had a marked
effect on insulin secretion measured in vitro and in vivo 10 min
after the onset of glucose challenge (i.e., when first-phase insulin
secretion was completed [Rorsman and Renstrom, 2003]).
Thus, a scenario in which Munc13-1 and CAPS proteins cooper-
ate in the recruitment of LDCVs can be envisaged. An additional
role for CAPS1 in the maintenance and stabilization of insulin
granules is also in accordance with the finding that lowered
CAPS1 expression reduces the number of LDCVs in adult chro-
maffin cells (Speidel et al., 2005).
General Conclusions and Pathophysiological
Significance
Our data obtained from CAPS2/ and CAPS1+/;CAPS2/
b cells demonstrate that exocytosis of insulin granules is depen-
dent on CAPS proteins and that CAPS ablation leads to destabi-
lization and recruitment of granules, resulting in reduced insulin
release and glucose intolerance in vivo. We point out that al-
though CAPS proteins are clearly involved in Ca2+-dependent
exocytosis of insulin-containing LDCVs in b cells, it is apparent
that exocytosis can proceed in the absence of these proteins
(Figure S1). Thus, CAPS proteins are not required for exocytosis,
and they are perhaps best described as modulators of LDCV
secretion.
Type 2 diabetes involves both insulin resistance and insuffi-
cient insulin secretion (Kahn et al., 2006), but it is now recognized
that impaired insulin secretion is a key factor (Szoke and Gerich,
2005). We show here that ablation of CAPS1 and/or CAPS2
results in impaired systemic glucose tolerance in vivo and sup-
pression of GSIS as well as oversecretion of glucagon in vitro.
The latter features mimic the hormonal disturbances in type 2 di-
abetes (Cryer, 2002). In man, CAPS1 and CAPS2 are encoded by
the genes CADPS and CADPS2, which reside on chromosomal
regions 3p14.2 and 7q31.3, respectively. Linkage studies sug-
gest a genetic association between these regions and plasma
insulin levels (Lakka et al., 2003; Mitchell et al., 2000) and the
metabolic syndrome (Loos et al., 2003). In diabetic GK rats,
a linkage between the chromosomal region encoding the rat
homolog of CAPS2 (chromosome 4q22) and GSIS has been re-
ported (Gauguier et al., 1996). Although the significance of these
findings should not be overstated, they suggest that both abnor-
mal expression of and polymorphisms in the genes encoding theCAPS proteins may contribute to the hormonal defects associ-
ated with human type 2 diabetes.
EXPERIMENTAL PROCEDURES
CAPS1 and CAPS2 KO mice
CAPS1+/ mice (Speidel et al., 2005) and recently generated CAPS2/ mice
(Jockusch et al., 2007) were used. CAPS2/ mice were generated by homol-
ogous recombination in embryonic stem cells as described previously
(Thomas and Capecchi, 1987). Briefly, an 18 kb genomic fragment containing
exons 2–6 of mouse CAPS2 from 129/SvJ mice was used to construct the tar-
geting vector. In the targeting vector, exon 5 (numbered according to the pub-
lished human sequence [Cisternas et al., 2003]) was replaced by a neomycin
resistance gene flanked by loxP sites. Following electroporation and selection,
recombinant stem cell clones were identified, one of which was injected into
mouse blastocysts. Highly chimeric mice were crossed with C57BL/6 mice
to transmit the mutation through the germline. CAPS2+/ mice were back-
crossed with C57BL/6 mice more than five times before they were inter-
crossed to obtain CAPS2/ and CAPS2+/+ mice for experiments. CAPS1+/;
CAPS2/ mice were generated initially by crossing CAPS1+/ mice with
CAPS2/ mice and finally by intercrossing CAPS1+/;CAPS2/ mice. The
observed phenotype of the CAPS2/ mice was independent of the parental
genotype (either CAPS2+/ or CAPS1+/;CAPS2/ mice). Littermates were
used for experiments to ensure identical genetic background. The mice
were housed at constant temperature (22C–23C) with a 12 hr light cycle
(6:00 a.m.–6:00 p.m.) and ad libitum access to standard pellet food and water.
All experiments were evaluated and approved by the local ethical committee
(Malmo¨/Lund djurfo¨rso¨ksetiska na¨mnd, Lund District Court, Sweden).
Islet Isolation and Islet Cell Preparation
The mice were sacrificed by cervical dislocation, and collagenase was admin-
istered into the pancreas by retrograde injection via the pancreatic duct. Islets
were collected manually, and islet cells were isolated and cultured as de-
scribed previously (Jing et al., 2005).
Confocal Microscopy
Freshly isolated islets were fixed with 4% paraformaldehyde and permeabi-
lized with 5% Triton X-100, and unspecific sites were blocked with 5% normal
donkey serum. Immunocytochemistry of islets was performed using poly-
clonal antibodies against CAPS1 and CAPS2 at 1:1000 and 1:500 dilutions,
respectively (Speidel et al., 2003). Primary insulin and glucagon antibodies
(Euro-Diagnostica), raised in guinea pigs and sheep, respectively, were incu-
bated at 1:1000. Following incubation with secondary antibodies conjugated
to either Cy5 or Cy2, confocal images were acquired with a LSM 510 confocal
microscope (Zeiss) by sequentially scanning at (excitation/emission) 488/505–
530 nm (Cy2) and 633/>650 nm (Cy5).
Electrophysiology
Measurements were conducted using an EPC 10 patch-clamp amplifier in
conjunction with the PULSE software suite (version 8.53, HEKA Elektronik).
Exocytosis was monitored as increases in cell capacitance using the sine +
DC mode of the lock-in amplifier included in the PULSE software and the stan-
dard whole-cell configuration as described in detail in Kanno et al. (2004). The
composition of the pipette and bath solutions used for experiments in Figures
3A and 3D, respectively, were identical to those employed previously (Jing
et al., 2005). Perforated-patch whole-cell recordings were carried out using
the pore-forming antibiotic amphotericin B as described previously (Renstrom
et al., 1996). The experiments commenced when the series resistance was
<50 MU.
Rhodamine Uptake and Image Analysis
Intact islets were immobilized using a suction pipette and equilibrated at 32C
in extracellular bath solution supplemented with 1 mM sulforhodamine B for
5 min. Exocytosis was stimulated by increasing the glucose concentration
from 5 mM to 20 mM. Fluorescence was imaged via two-photon Zeiss LSM
510 META confocal microscopy (403 water immersion objective; NA 1.2,
Zeiss C-Apochromat). The dye was excited with 800 nm light from a Verdi
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cence was detected using a 560 nm short pass filter. Images were acquired at
1 Hz. Sites of exocytosis were detected manually.
Electron Microscopy and Analysis of Electron Micrographs
Freshly isolated pancreatic islets were fixed in 2.5% glutaraldehyde for 1 hr,
treated with 1% osmium tetroxide, dehydrated, and embedded in Durcupan.
Sectioning, contrasting, and monitoring of islet areas was performed as de-
scribed previously (Olofsson et al., 2002). To determine cellular granule distri-
bution, cell area and distance of the granules to the plasma membrane were
measured using in-house MATLAB-based software.
Determination of Hormone Content and Hormone Release
Islet hormone release in vitro was measured in static incubations. Briefly,
batches of freshly isolated islets (7 and 50 islets per tube for Figures 2A
and 2B, respectively) were preincubated for 30 min at 37C in Krebs-Ringer
bicarbonate buffer (pH 7.4) containing 1 mM glucose before islet hormone re-
lease was stimulated by addition of 20 mM glucose, 50 mM K+, or 100 nM
GLP-1. Immediately after incubation, 100 ml aliquots of the medium were
removed for assay of insulin, glucagon, and somatostatin as described pre-
viously (Salehi et al., 1999; Zhang et al., 2007). The content of mature (i.e.,
fully processed) insulin present in islets was determined by radioimmunoas-
say (RIA) following acidic alcohol extraction (Salehi et al., 1999). Proinsulin
content and release were determined by ELISA (Rat Proinsulin ELISA Kit,
Mercodia). Protein concentration was determined using a DC protein assay
from Bio-Rad.
In Vivo Glucose Challenges and Insulin Sensitivity Assay
For the in vivo glucose challenge, glucose (11.1 mmol [equivalent to 2 g/kg
body weight]) was dissolved in 0.9% NaCl and delivered by intraperitoneal
injection. For the insulin sensitivity assay, 0.5 IU insulin/kg body weight
(Actrapid, Novo Nordisk) was dissolved in 0.9% NaCl and delivered by intra-
peritoneal injection. Blood sampling was performed in unanesthetized mice
(with the ethical consent of Malmo¨/Lund djurfo¨rso¨ksetiska na¨mnd, Lund
District Court, Sweden). Plasma insulin concentrations were determined by
RIA, and enzymatic determination of plasma glucose concentrations was per-
formed as described previously (Salehi et al., 1999).
Determination of Lysosomal Enzyme Activities
Fifty freshly isolated islets were thoroughly washed in glucose-free Hank’s
solution and dissolved by sonication in 200 ml acetate-EDTA buffer (1.1 mM
EDTA, 5 mM actetate [pH 5.0]), and aliquots were used for determination of
lysosomal enzyme activity as described previously (Lundquist, 1985).
Statistics
The level of significance for the difference between data sets was assessed
using Student’s unpaired t test. Results are expressed as mean ± SEM.
Supplemental Data
Supplemental Data include three figures and two movies and can be found
with this article online at http://www.cellmetabolism.org/cgi/content/full/7/1/
57/DC1/.
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